68Ga-DOTATOC PET/CT of neuroendocrine tumors: Spotlight on the CT phases of a triple-phase protocol

Journal of Nuclear Medicine

Volumn 52, Issue 5, 2011, Pages 697-704

  Ruf, Juri ^a,b   Schiefer, Jan ^a   Furth, Christian ^a   Kosiek, Ortud ^a   Kropf, Siegfried ^c   Heuck, Friederike ^b   Denecke, Timm ^b   Pavel, Marianne ^b   Pascher, Andreas ^b   Wiedenmann, Bertram ^b   Amthauer, Holger ^a,b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

68Ga DOTATOC; Multiphase CT protocol; NET; Neuroendocrine tumor; PET CT

Indexed keywords

GALLIUM 68 DOTATOC; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GA(III) DOTATOC; GA(III)-DOTATOC; OCTREOTIDE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ARTERY; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOPHYSIOLOGY; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; VASCULARIZATION;

ADULT; AGED; ARTERIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OBSERVER VARIATION; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; PORTAL VEIN; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955759589     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.083741     Document Type: Article

References (31)

1. Nissen NN, Kim AS, Yu R, et al. Pancreatic neuroendocrine tumors: presentation, management, and outcomes. Am Surg. 2009;75:1025-1029.
2. Yildiz O, Ozguroglu M, Yanmaz T, Turna H, Serdengecti S, Dogusoy G. Gastro-enteropancreatic neuroendocrine tumors: 10-year experience in a single center. Med Oncol. 2010;27:1050-1056.
3. Makridis C, Oberg K, Juhlin C, et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg. 1990;14:377-383
4. Oberg K, Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:265-276. (Pubitemid 40347816)
5. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RC II. A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg. 2008;196:896-903.
6. Jonas S, John M, Boese-Landgraf J, et al. Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues. Langenbecks Arch Chir. 1995;380:90-95.
7. Kwekkeboom DJ, Krenning EP, Scheidhauer K, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with 111In-pentetreotide. Neuroendocrinology. 2009;90:184-189.
8. Gabriel M, Decristoforo C, Kendler D, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508-518. (Pubitemid 47571404)
9. 111In-DTPAOC (OctreoScan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2007;34:1617-1626.
10. Khan MU, Khan S, El-Refaie S, Win Z, Rubello D, Al-Nahhas A. Clinical indications for gallium-68 positron emission tomography imaging. Eur J Surg Oncol. 2009;35:561-567.
11. 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology. 2010;91:101-109.
12. Paulson EK, McDermott VG, Keogan MT, DeLong DM, Frederick MG, Nelson RC. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology. 1998;206:143-150. (Pubitemid 28062998)
13. Sundin A, Vullierme MP, Kaltsas G, Plockinger U. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. Neuroendocrinology. 2009;90:167-183.
14. 18F-TOCA PET, triple-phase CT, and PET/ CT. Technol Cancer Res Treat. 2007;6:213-220.
15. 68Ga for medical application. J Nucl Med. 2007;48:1741-1748.
16. Denecke T, Grieser C, Froling V, et al. Multislice computed tomography using a triple-phase contrast protocol for preoperative assessment of hepatic tumor load in patients with hepatocellular carcinoma before liver transplantation. Transpl Int. 2009;22:395-402.
17. Ay MR, Zaidi H. Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET. Eur J Nucl Med Mol Imaging. 2006;33:1301-1313. (Pubitemid 44630786)
18. Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics. 2007;27:145-159.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174. (Pubitemid 8054849)
20. 18F]FP)-TOCA: correlation between uptake, size and arterial perfusion in somatostatin receptor positive lesions. Eur J Nucl Med Mol Imaging. 2008;35:264-271.
21. Kumbasar B, Kamel IR, Tekes A, Eng J, Fishman EK, Wahl RL. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS. Abdom Imaging. 2004;29:696-702. (Pubitemid 39331706)
22. 68Ga-DOTATOC PET/CT examinations [in German]. Nuklearmedizin. 2009;48: 201-207
23. Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom AT. Long-term results of continuous treatment with recombinant interferon- alpha in patients with metastatic carcinoid tumors: an antiangiogenic effect? Anticancer Drugs. 1996;7:175-181.
24. Oberg K. Interferon in the management of neuroendocrine GEP-tumors: a review. Digestion. 2000;62(suppl 1):92-97. (Pubitemid 30665946)
25. Grozinsky-Glasberg S, Shimon I, Korbonits M, Grossman AB. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms. Endocr Relat Cancer. 2008;15:701-720.
26. Bae KT. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology. 2010;256:32-61.
27. 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2010;37:722-727.
28. Horton KM, Hruban RH, Yeo C, Fishman EK. Multi-detector row CT of pancreatic islet cell tumors. Radiographics. 2006;26:453-464. (Pubitemid 43515317)
29. Liu C, Pierce LA II, Alessio AM, Kinahan PE. The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging. Phys Med Biol. 2009;54:7345-7362.
30. 18F-FDG PET. J Nucl Med. 2010;51:704-712.
31. Dewey M, Hoffmann H, Hamm B. CT coronary angiography using 16 and 64 simultaneous detector rows: intraindividual comparison. Rofo. 2007;179:581-586. (Pubitemid 47091680)